CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels

1.4 min readPublished On: January 18th, 2023By

SAN DIEGO, CV Sciences, a consumer wellness company known for their expertise in hemp extracts and other natural ingredients, recently announced the launch of their popular +PlusCBD™ Reserve Collection Softgels in a 30-count bottle. This new offering will be available on +PlusCBD’s website starting January 19th.

The +PlusCBD™ Reserve Collection Softgels were initially launched in August 2022 as the newest addition to CV Sciences’ Reserve Collection. The softgels are formulated with a 10:1 ratio of CBD to THC (12.5mg CBD to 1.25mg THC), and contain a full spectrum of cannabinoids to meet the needs of consumers who require intense support. The softgels elicit feelings of relief and calm and are available in a 60-count bottle as well.

The launch of the 30-count bottle offers consumers more flexibility and options in terms of personalizing their intake routine. With the new 30-count bottle, the price point of the Reserve Softgels is also more affordable at $37.99 USD.

CV Sciences’ CEO, Joseph Dowling, states, “Consumers have quickly adopted Reserve Softgels into their lifestyles, appreciating the product’s easy-to-take and familiar format as well as its life-enhancing effects.” The new 30-count bottle option will make the softgels more accessible to a wider range of budgets and is expected to encourage more consumers to try the product.

The +PlusCBD™ Reserve Collection Softgels are a natural solution for reducing stress, anxiety and depression. With the launch of the new 30-count bottle, the softgels are now more affordable and accessible than ever before. Head over to the +PlusCBD website on January 19th to purchase the new 30-count bottle for $37.99 USD.

(This information is primarily sourced from Reportlinker.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News